Navigation Links
STC.UNM Signs License Option Agreement With GeneThera for E. coli O157:H7 Vaccine
Date:10/27/2008

WHEAT RIDGE, Colo., Oct. 27 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR), announced today that it has signed an agreement with STC.UNM (STC), the technology-transfer arm of the University of New Mexico (UNM), giving GeneThera an option to a license to worldwide development and distribution rights to a vaccine developed at UNM's Health Sciences Center that is designed to significantly inhibit the carriage and shedding of the E. coli bacteria in cattle.

The technology consists of a vaccine that when given to cattle reduces and inhibits the carriage and shedding of enterohemorrhagic E. coli (such as serotype O157:H7). This vaccine consists of live attenuated bacteria that were created for this purpose by Dr. Edgar Boedeker, a Professor in the Internal Medicine Department at UNM's Health Sciences Center, and Dr. Chengru Zhu, formerly of UNM but now Chief of Environmental Microbiology in the Maryland Department of Health. These bacteria are harmless to humans and animals because the key virulence genes of the bugs are mutated by molecular approaches.

According to the CDC, " ... there may be about 70,000 infections with E. coli O157 each year in the United States. We can only estimate because we know that many infected people do not seek medical care, many do not submit a stool specimen for testing, and many labs do not test for STEC. The bacteria that make these toxins are called 'Shiga toxin producing' E. coli, or STEC for short."

Shiga toxin is one of the most potent toxins known to man, so much so that the Centers for Disease Control and Prevention (CDC) lists it as a potential bioterrorist agent (CDC, n.d.).

This vaccine, when used in cattle, inhibits the carrying and shedding of bacteria that are known to induce food borne illness such as E. coli O157:H7. Vaccinated cattle will have a greatly diminished ability to carry and shed these pathogenic bacteria. The result will be the reduced contamination of meat and wat
'/>"/>

SOURCE GeneThera, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
2. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Monsanto Company Signs Share Subscription Agreement With Devgen
5. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
6. Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company
7. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
8. Assay Designs(TM) Announces Additions to the Leadership Team
9. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 Demanding industrial and environmental conditions ... synthetic Sapphire and Glass Ball Lenses, now available in ... Jewel Company , of Philadelphia , PA. , Optical ... the light beams without the need for direct physical ... durability (9 mohs) make it the ideal choice for ...
(Date:6/18/2013)... RegeneCure announced today the start of a ... (GBR) Dental Membrane as a bone stimulating aid for patients ... patients have a tooth replaced with a dental implant is ... Consequently there is often a need to support the implant ... bone substitute material, in turn, needs to be held in ...
(Date:6/18/2013)... , June 18, 2013  AMRI (NASDAQ: ... Burlington, Mass. , site has ... Enforcement Administration (DEA) registration to handle Schedule 2 ... DEA,s acknowledgement of Burlington,s ... and documentation. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...
(Date:6/18/2013)... 18, 2013 This webinar will ... advertising and promotion, and review the basic FDA ... how to apply these principles through real world ... ,     The fundamentals on FDA regulations and guidance ... ,     Assessing traditional and newer forms of ...
Breaking Biology Technology:Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2
... S.A., a,French drug and diagnostic discovery company, today announces ... 2007., 2007 Key Events, - Milestone reached ... AGN ) in view of the initiation of Phase ... - Approval by the AFSSAPS (Agence Francaise de ...
... Germany, March 5 In mid-March the German,Bundestag (Lower ... the German Stem,Cell Act. The opposing poles in the ... apart: its proponents are calling for the complete,liberalisation of ... of a,general ban on the use of human stem ...
... Statins Alone, in Decreasing Cardiovascular Events in Diabetics with Haptoglobin ... ... March 5 Synvista,Therapeutics, Inc. (Amex: SYI ) announces the publication ... E to statin therapy prevented more cardiovascular events (heart,attack, stroke and cardiovascular ...
Cached Biology Technology:ExonHit Therapeutics - 2007 Financial Results 2ExonHit Therapeutics - 2007 Financial Results 3ExonHit Therapeutics - 2007 Financial Results 4ExonHit Therapeutics - 2007 Financial Results 5ExonHit Therapeutics - 2007 Financial Results 6ExonHit Therapeutics - 2007 Financial Results 7ExonHit Therapeutics - 2007 Financial Results 8ExonHit Therapeutics - 2007 Financial Results 9ExonHit Therapeutics - 2007 Financial Results 10ExonHit Therapeutics - 2007 Financial Results 11ExonHit Therapeutics - 2007 Financial Results 12A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy 2A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy 3Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 2Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 3Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 4
(Date:6/17/2013)... French . ... with Alzheimer,s disease can be reversed with treatment. The study ... The Neuro, at McGill University and at Universit de Montral ... the brain of mice with advanced Alzheimer,s disease (AD) recovers ... Journal of Neuroinflammation in May, also suggest an underlying ...
(Date:6/16/2013)... cells use to group together and move around the body ... the first time by scientists at UCL. , Published ... on the process that occurs when cancer cells interact with ... metastasis. Scientists know that cancer cells recruit healthy cells and ... takes place and how it could be controlled to design ...
(Date:6/14/2013)... understanding and explaining how evolution operates. In search ... at Michigan State University developed complete evolutionary case ... underlying an evolving characteristic to their genetic consequences ... T. White, Merle K. Heidemann, and James J. ... a cellular and molecular biology course taught to ...
Breaking Biology News(10 mins):Blocking overactive receptor in Alzheimer's recovers memory loss and more 2'Chase and run' cell movement mechanism explains process of metastasis 2Teaching complete evolutionary stories increases learning 2
... Cancerous tumors are wildly unfavorable environments. Struggling ... the bodys defense systems, tumor cells in fact ... decades, scientists have sought ways to circumvent these ... University of Massachusetts Medical School (UMMS), have defined ...
... - BioMed Central today announced the launch of Biology ... over 11,000 carefully selected biology-related images. This is ... Science Navigation Group of companies which was also responsible ... resource. The Library is a new subscription-based service ...
... public health issue and economic problem has been ... the University Denis Diderot in Paris, and the ... chlorine-resistant parasites, known as Cryptosporidium, which cause a ... significant mortality in immunodeficient patients, become virtually inactive ...
Cached Biology News:Sidestepping cancer's chaperone 2Ultraviolet light helps to secure water supply 2
... 384 is a compact and self-contained ... is a unique flow-through device, which ... included wash system. Optional refill ... system. Will be upgradable to ...
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... Caliper's iLink makes it easy to ... laboratory instruments. Developed with operator convenience in ... and shoot' ease of use. The iLink ... workstations for assays or sub-assays, that can ...
... meet your laboratory's requirements for data management and quality control. ... ... ... the standard software for Staccato Systems and custom Allegro Modules allowing for the simple interface with ...
Biology Products: